The role of low-molecular-weight heparin in the management of acute coronary syndromes
Open Access
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (4) , S55-S61
- https://doi.org/10.1016/s0735-1097(02)02901-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS studyClinical Cardiology, 2001
- Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: One-year results of the essence studyJournal of the American College of Cardiology, 2000
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Published by Elsevier ,2000
- Economic Evaluation of Enoxaparin Sodium versus Heparin in Unstable AnginaPharmacoEconomics, 2000
- Can we differentiate the low-molecular-weight heparins?Clinical Cardiology, 2000
- Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary SyndromesPharmacoEconomics, 1999
- EptifibatideDrugs, 1999
- TirofibanDrugs, 1998
- AbciximabDrugs, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997